Sagent launches cefazolin for injection in 500mg single-dose vial

The 500mg single-dose vial expands Sagent’s existing line of cefazolin products beyond the 1gm single-dose vials and 10gm pharmacy bulk package vials launched in March 2008. All doses are completely latex-free and include enhanced packaging features such as bar-coding and labeling designed to reduce confusion among doses, the company said.

Cefazolin for injection, USP, is the generic equivalent of Kefzol, an antibiotic used to treat bacterial infections. Sagent will begin marketing and shipping cefazolin in the 500mg single-dose vials immediately.

Lorin Drake, vice president of sales and marketing at Sagent, said: “The innovative labeling we brought to our other cefazolin products is now available on a 500mg single-use vial, allowing clinicians access to an extended line of cefazolin for injection designed with medication safety in mind. Our enhanced cefazolin packaging designs incorporate specific features in response to needs expressed by our customers.”